Orjuela-Grimm, Manuela http://orcid.org/0000-0002-7385-7561
Butsch, W. Scott
Bhatt-Carreño, Silvia
Smolarz, B. Gabriel http://orcid.org/0000-0002-8591-3858
Rao, Goutham
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 27 July 2020
Accepted: 7 June 2021
First Online: 24 June 2021
Declarations
:
: Ethical approval has been exempted by Columbia University Institutional Review Board, August 16, 2018, reference number IRB-AAAS0063. Prior to completing surveys, respondents provided informed consent electronically, i.e., by selecting “yes” to the question “Do you consent to these terms and wish to continue with the following survey on obesity medicine education?”.
: Not applicable.
: Dr. Orjuela-Grimm has no conflicts of interest to disclose.Dr. Butsch is a health consultant for Novo Nordisk Inc. and on an advisory board for Rhythm Pharmaceuticals, Inc.Ms. Bhatt-Carreño has no conflicts of interest to disclose.Dr. Smolarz is an employee of Novo Nordisk and owns stock in Novo Nordisk.Dr. Rao has no conflicts of interest to disclose.